---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-006381"
form_type: "8-K"
ticker: "ELUT"
cik: "0001708527"
company_name: "ELUTIA INC."
filed_at: "2023-04-21T23:59:59+00:00"
generated_at: "2026-06-16T21:26:05.260837+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Aziyo Biologics grants LeMaitre exclusive US distribution rights for cardiovascular products

## Summary
- Three-year exclusive US distribution deal for ProxiCor PC, ProxiCor CTR, Tyke, and VasCure.
- LeMaitre has an exclusive option to acquire the product line after year one; price based on multiple of trailing 12-month sales.
- Initial purchase and minimum purchase volumes start Oct 1, 2023; prices subject to annual adjustment.
- Aziyo CEO cites focus on CanGaroo Envelope for implantable electronic devices after this partnership.
- LeMaitre President says the deal adds next-gen extracellular matrix patches to its US product offering.

## SEC filing metadata
- accession: 0001558370-23-006381
- form_type: 8-K
- ticker: ELUT
- cik: 0001708527
- company_name: ELUTIA INC.
- filed_at: 2023-04-21T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708527/000155837023006381/0001558370-23-006381-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708527/000155837023006381/azyo-20230420x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-006381
- JSON: https://secwatch.observer/filing/0001558370-23-006381.json
- Plain text: https://secwatch.observer/filing/0001558370-23-006381.txt

## Key facts
- Material Agreements
  ELUTIA INC. entered into Distribution Agreement with LeMaitre Vascular, Inc. (effective 2023-04-20).
  - Action: entry
  - Agreement: supply
  - Counterparty: LeMaitre Vascular, Inc.
  - Effective: 2023-04-20
  source text: On April 20, 2023, Aziyo Biologics, Inc. (the “Company” or “Aziyo”) entered into a Distribution Agreement (the “Agreement”) with LeMaitre Vascular, Inc., a Delaware corporation (“LeMaitre”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708527/000155837023006381/0001558370-23-006381-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.